- Brands
- Offerings
- Diagnostic Panels
- Knowledge Center
- Diagnostics
With over 70% of medical decisions based on test results, laboratory diagnostics need to be considered as an integrated medical discipline.1
Lab Performance Benchmarking aids an organisation to measure and understand where it is positioned amongst its peers, how far it needs to go before it reaches the top and what efficiencies can be made to help it achieve a measurably better healthcare performance.
The Lab Performance Benchmarking initiative from Core Diagnostics at Abbott focuses on best practices to identify ‘next’ practices and provides laboratories taking part with the knowledge they need to strive for continuous lab performance improvement, against key performance indicators (KPIs), by enabling identification of areas that need to be adapted or modified in order to better meet customer needs.
"It is quite reassuring that we are very well placed among our peers and that
our strategic input is accurate, however, there are a lot of drivers to focus more on efficiency.
In particular, we should drive the digital transformation forward."
Abbott talked to 773 laboratories from 39 countries across Europe, Middle East and Africa (EMEA).
This Lab Performance Benchmarking initiative aims to provide laboratories with a means to understand how they compare to peers, as well as enabling them to better position their value to clinical and non-clinical decision makers responsible for managing partnerships with laboratories.
Find out how your lab compares on metrics such as clinician expectation time (CET),
turnaround time (TAT), ISO 15189 Accreditation,
Lean Six Sigma, staff productivity and so much more.
The diagnosis cycle starts before samples arrive at the laboratory yet monitoring often doesn’t begin until the samples arrive. For clinicians, their waiting time starts as soon as they make a request, this is known as clinician expectation time (CET).
ISO 15189 accreditation underpins confidences in the quality of medical laboratories through a process that verifies integrity, impartiality, and competence. Accreditation to ISO 15189 varies across EMEA with largest uptake in France.
Laboratories across EMEA report a shortage of staff. This shortage is more pronounced for higher skilled staff compared to lower skilled staff and more obvious in the commercial than in the hospital sector.
Staff productivity in labs with automation for clinical chemistry, immunoassay and hematology process higher quantities of samples and tests per full-time equivalent (FTE).
The Lab Performance Benchmark report aims to help labs to stay ahead by first illustrating where they stand when compared to their peers. It enables labs to understand gaps in current provision to identify areas where they can differentiate to achieve business goals and outperform peers.
Learn about the innovative total laboratory automation solution with proven technology and flexibility to meet your goals.
Build key laboratory competencies and explore topics from various disciplines with our learning guides.
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.